Renaissance Applied sciences LLC boosted its stake in shares of U.S. Bodily Remedy, Inc. (NYSE:USPH – Free Report) by 763.7% within the second quarter, in keeping with its most up-to-date submitting with the Securities and Alternate Fee (SEC). The agency owned 69,523 shares of the corporate’s inventory after buying a further 61,474 shares in the course of the quarter. Renaissance Applied sciences LLC’s holdings in U.S. Bodily Remedy have been value $6,425,000 on the finish of the latest reporting interval.
Quite a few different institutional traders have additionally lately added to or diminished their stakes in USPH. Vanguard Group Inc. raised its holdings in shares of U.S. Bodily Remedy by 1.0% in the course of the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the corporate’s inventory valued at $121,065,000 after shopping for a further 10,175 shares over the last quarter. Southernsun Asset Administration LLC raised its stake in U.S. Bodily Remedy by 5.9% in the course of the 4th quarter. Southernsun Asset Administration LLC now owns 479,214 shares of the corporate’s inventory valued at $44,634,000 after buying a further 26,758 shares within the final quarter. Schroder Funding Administration Group boosted its place in U.S. Bodily Remedy by 11.0% in the course of the 4th quarter. Schroder Funding Administration Group now owns 427,217 shares of the corporate’s inventory value $39,791,000 after buying a further 42,281 shares in the course of the interval. Dimensional Fund Advisors LP grew its stake in shares of U.S. Bodily Remedy by 2.5% within the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the corporate’s inventory value $39,173,000 after buying a further 10,462 shares within the final quarter. Lastly, Envestnet Asset Administration Inc. elevated its holdings in shares of U.S. Bodily Remedy by 4.1% in the course of the second quarter. Envestnet Asset Administration Inc. now owns 239,982 shares of the corporate’s inventory valued at $22,179,000 after buying a further 9,434 shares in the course of the interval.
U.S. Bodily Remedy Value Efficiency
Shares of U.S. Bodily Remedy inventory opened at $84.32 on Thursday. The corporate’s 50-day transferring common worth is $87.80 and its two-hundred day transferring common worth is $96.58. The inventory has a market cap of $1.27 billion, a PE ratio of 68.55, a price-to-earnings-growth ratio of 4.07 and a beta of 1.39. The corporate has a present ratio of 1.88, a fast ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Bodily Remedy, Inc. has a 52 week low of $78.08 and a 52 week excessive of $113.63.
U.S. Bodily Remedy (NYSE:USPH – Get Free Report) final issued its earnings outcomes on Tuesday, August thirteenth. The corporate reported $0.73 earnings per share for the quarter, lacking analysts’ consensus estimates of $0.82 by ($0.09). U.S. Bodily Remedy had a return on fairness of 8.18% and a internet margin of 4.06%. The enterprise had income of $167.19 million for the quarter, in comparison with the consensus estimate of $163.34 million. Throughout the identical quarter within the earlier 12 months, the enterprise posted $0.76 earnings per share. The corporate’s quarterly income was up 10.4% on a year-over-year foundation. As a bunch, sell-side analysts anticipate that U.S. Bodily Remedy, Inc. will publish 2.51 EPS for the present fiscal 12 months.
U.S. Bodily Remedy Dividend Announcement
The enterprise additionally lately introduced a quarterly dividend, which was paid on Friday, September thirteenth. Stockholders of file on Friday, August twenty third have been issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of two.09%. The ex-dividend date of this dividend was Friday, August twenty third. U.S. Bodily Remedy’s dividend payout ratio is 143.09%.
Analysts Set New Value Targets
Quite a few brokerages lately issued stories on USPH. StockNews.com upgraded shares of U.S. Bodily Remedy from a “promote” ranking to a “maintain” ranking in a analysis report on Wednesday, August twenty first. Barrington Analysis reiterated an “outperform” ranking and issued a $108.00 worth goal on shares of U.S. Bodily Remedy in a report on Friday, September twentieth.
View Our Newest Analysis Report on U.S. Bodily Remedy
Insider Exercise at U.S. Bodily Remedy
In associated information, Director Kathleen A. Gilmartin acquired 2,000 shares of the enterprise’s inventory in a transaction on Tuesday, September third. The shares have been bought at a median worth of $86.09 per share, for a complete transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares within the firm, valued at $1,627,445.36. The transaction was disclosed in a doc filed with the SEC, which will be accessed by means of the SEC web site. In associated information, COO Graham D. Reeve offered 1,724 shares of the corporate’s inventory in a transaction on Wednesday, August twenty first. The inventory was offered at a median worth of $82.50, for a complete transaction of $142,230.00. Following the transaction, the chief working officer now instantly owns 7,038 shares of the corporate’s inventory, valued at $580,635. The transaction was disclosed in a authorized submitting with the Securities & Alternate Fee, which will be accessed by means of this hyperlink. Additionally, Director Kathleen A. Gilmartin acquired 2,000 shares of the agency’s inventory in a transaction on Tuesday, September third. The shares have been acquired at a median worth of $86.09 per share, with a complete worth of $172,180.00. Following the completion of the transaction, the director now instantly owns 18,904 shares within the firm, valued at roughly $1,627,445.36. The disclosure for this buy will be discovered right here. 1.70% of the inventory is at present owned by company insiders.
U.S. Bodily Remedy Profile
U.S. Bodily Remedy, Inc operates outpatient bodily remedy clinics. The corporate operates by means of Bodily Remedy Operations and Industrial Harm Prevention Providers segments. The corporate supplies pre-and post-operative care and remedy for orthopedic-related issues, sports-related accidents, preventative care, rehabilitation of injured staff, and neurological-related accidents.
Learn Extra
Wish to see what different hedge funds are holding USPH? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for U.S. Bodily Remedy, Inc. (NYSE:USPH – Free Report).
Obtain Information & Scores for U.S. Bodily Remedy Each day – Enter your electronic mail handle under to obtain a concise each day abstract of the newest information and analysts’ scores for U.S. Bodily Remedy and associated corporations with MarketBeat.com’s FREE each day electronic mail e-newsletter.